Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?
| dc.contributor.author | Porter, Ross John | |
| dc.contributor.author | Andrews, Caroline | |
| dc.contributor.author | Brice, Daniel Paul | |
| dc.contributor.author | Durum, Scott Kenneth | |
| dc.contributor.author | McLean, Mairi Hall | |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2019-07-17T23:04:06Z | |
| dc.date.available | 2019-07-17T23:04:06Z | |
| dc.date.embargoedUntil | 2019-07-18 | |
| dc.date.issued | 2018-09-15 | |
| dc.description | Drs. Andrews and Durum are supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, National Institutes of Health, USA. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 641921 | |
| dc.identifier | 125122905 | |
| dc.identifier | 75128111-a520-40ea-bc65-906f8cfab7ad | |
| dc.identifier | 85056844442 | |
| dc.identifier.citation | Porter, R J, Andrews, C, Brice, D P, Durum, S K & McLean, M H 2018, 'Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?', Inflammatory Bowel Diseases, vol. 24, no. 10, pp. 2123-2134. https://doi.org/10.1093/ibd/izy230 | en |
| dc.identifier.doi | 10.1093/ibd/izy230 | |
| dc.identifier.iss | 10 | en |
| dc.identifier.issn | 1078-0998 | |
| dc.identifier.other | ORCID: /0000-0002-7443-2653/work/94084011 | |
| dc.identifier.uri | http://hdl.handle.net/2164/12590 | |
| dc.identifier.vol | 24 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Inflammatory Bowel Diseases | en |
| dc.subject | Inflammatory Bowel Disease | en |
| dc.subject | immunoregulation | en |
| dc.subject | cytokine | en |
| dc.subject | ulcerative colitis | en |
| dc.subject | Crohn's disease | en |
| dc.subject | treatment | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? | en |
| dc.type | Journal item | en |
